Treatment
Metreleptin clinical trials
We’re tracking 5 recruiting studies that include Metreleptin, each written for real people, not researchers, below.
Recruiting studies
- NCT06484868RecruitingPhase 4
Study of metreleptin for partial lipodystrophy
This trial tests an open-label study of metreleptin in people with partial lipodystrophy, a condition where fat is lost from some areas of the body. The goal is to see if the drug can help manage related health problems.
LilleAges 12 years+ - NCT06305182RecruitingPhase 2
Metreleptin for Anorexia Nervosa
This study tests a drug called metreleptin (a version of a hormone that helps regulate appetite and weight) in people hospitalized for anorexia nervosa. It may help with weight restoration and mood.
Zurich, Canton of ZurichAges 17–65 - NCT06679270RecruitingPhase 3
Long-term safety study of metreleptin for partial lipodystrophy
This study tests the long-term safety of metreleptin for people with partial lipodystrophy. It is for those who already completed a related study and want to continue treatment.
Birmingham, AlabamaAges 13 years+ - NCT02325674Recruiting
Metreleptin safety and effectiveness registry
This registry follows people who are already taking metreleptin (a medicine for certain rare conditions) to better understand its long-term safety and how well it works in everyday use. It may help you and other patients by building real-world evidence about this treatment.
Birmingham, AlabamaAges Any age - NCT05419037Recruiting
Study of pregnancy outcomes in people with lipodystrophy
This study looks at how pregnancy goes and what birth outcomes happen in women with lipodystrophy, comparing those who used metreleptin during pregnancy versus those who did not. It also collects information and blood samples from the children so researchers can better understand the effects of metreleptin during pregnancy.
Bethesda, MarylandAges 6 months–98 years
What Metreleptin is being studied for
Conditions with recruiting Metreleptin studies.
Common questions
- Are there clinical trials studying Metreleptin?
- Yes. Clin2 currently lists 5 recruiting studies that include Metreleptin, drawn from the U.S. registry and rewritten for real people so you can see what each is testing and who it's for.
- How do I know if I qualify for a Metreleptin trial?
- Each study lists its own eligibility criteria — rules about condition, age, and prior treatments. On every Clin2 trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Is Metreleptin an approved treatment?
- A drug being studied in a trial may be investigational (still being tested) or already approved and being studied for a new use. Each study page explains what phase it's in. Clin2 does not provide medical advice — talk with your doctor about whether Metreleptin or a specific trial is right for you.
Related treatments
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. A drug appearing here is being studied in a trial and may be investigational. Talk with your doctor about whether a specific treatment or trial is right for you.